共 27 条
- [1] Anderson D.K., Means E.D., Waters T.R., Green E.S., Microvascular perfusion and metabolism in injured spinal cord after methylprednisolone treatment, J Neurosurg, 56, pp. 106-113, (1982)
- [2] Anderson D.K., Demediuk P., Saunders R.D., Dugan L.L., Means E.D., Horrocks L.A., Spinal cord injury and protection, Ann Emerg Med, 14, pp. 816-821, (1985)
- [3] Bracken M.B., Shepard M.J., Collins W.F., Et al., A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury, N Engl J Med, 322, 20, pp. 1405-1411, (1990)
- [4] Braughler J.M., Hall E.D., Correlation of methylprednisolone levels in cat spinal cord with its effects on (NaK)- ATPase, lipidperoxidation, and alpha motor neuron function, J Neurosurg, 56, pp. 838-844, (1982)
- [5] Diamant B., Karlsson J., Nachemson A., Correlation between lactate levels and pH in discs of patients with lumbar rhizopathies, Experientia, 24, pp. 1195-1196, (1968)
- [6] Demopoulos H.B., Flamm E.S., Seligman M.L., Petronigro D.D., Tomasula J., Decrescito V., Further studies on free-radical pathology in the major central nervous system disorders: Effect on very high doses of methylprednisolone on the functional outcome, morphology, and chemistry of experimental spinal cord impact injury, Can J Physiol Pharmacol, 60, pp. 1415-1423, (1982)
- [7] Hall E.D., Wolf D.L., A pharmacological analysis of the pathophysiological mechanisms of posttraumatic spinal cord ischemia, J Neurosurg, 64, pp. 951-961, (1986)
- [8] Hall E.D., The neuroprotective pharmacology of methyl-prednisolone, J Neurosurg, 76, pp. 13-22, (1992)
- [9] Holmes J.M., Sworn B.R., Lumbosacral root pain, Br Med J, 1, (1946)
- [10] Jaffray D., Resorption O.B., A source of mechanical and inflammatory back pain?, Spine, 11, pp. 397-401, (1986)